{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T09:29:09Z","timestamp":1795080549366,"version":"4.10.2"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Science for Equity Empowerment and Development (SEED) Division, Department of Science and Technology, Government of India","award":["SEED\/WS\/2019\/540"],"award-info":[{"award-number":["SEED\/WS\/2019\/540"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-32974-z","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T06:35:16Z","timestamp":1767162916000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparative analysis of low-dose letrozole versus GnRH agonist on implantation markers and IVF outcomes in symptomatic adenomyosis: a randomized trial"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2402-3891","authenticated-orcid":false,"given":"Sunita","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sourav","family":"RoyChoudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratip","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranab","family":"Paladhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishan","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"Karan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhendu","family":"Hazra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhra Prakash","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratna","family":"Chattopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arup Kumar","family":"Majhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"key":"32974_CR1","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1093\/humrep\/des332","volume":"27","author":"J Naftalin","year":"2012","unstructured":"Naftalin, J. et al. How common is adenomyosis? A prospective study of prevalence using transvaginal ultrasound in a gynaecology clinic. Hum. Reprod. 27, 3432\u20133439 (2012).","journal-title":"Hum. Reprod."},{"key":"32974_CR2","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/humupd\/dms006","volume":"18","author":"A Maheshwari","year":"2012","unstructured":"Maheshwari, A., Gurunath, S., Fatima, F. & Bhattacharya, S. Adenomyosis and subfertility: a systematic review of prevalence, diagnosis, treatment and fertility outcomes. Hum. Reprod. Update. 18, 374\u2013392 (2012).","journal-title":"Hum. Reprod. Update"},{"key":"32974_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.rbmo.2011.10.003","volume":"24","author":"S Campo","year":"2012","unstructured":"Campo, S., Campo, V. & Benagiano, G. Adenomyosis and infertility. Reprod. Biomed. Online. 24, 35\u201346 (2012).","journal-title":"Reprod. Biomed. Online"},{"key":"32974_CR4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/ijgo.14609","volume":"161","author":"JL Alc\u00e1zar","year":"2023","unstructured":"Alc\u00e1zar, J. L. et al. Transvaginal ultrasound versus magnetic resonance imaging for diagnosing adenomyosis: A systematic review and head-to-head meta-analysis. Int. J. Gynaecol. Obstet. 161, 397\u2013405 (2023).","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"32974_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13669-021-00320-5","volume":"11","author":"T Tellum","year":"2022","unstructured":"Tellum, T. & Munro, M. G. Classifications of adenomyosis and correlation of phenotypes in imaging and histopathology to clinical outcomes: A review. Curr. Obstet. Gynecol. Rep. 11, 1\u201311 (2022).","journal-title":"Curr. Obstet. Gynecol. Rep."},{"key":"32974_CR6","doi-asserted-by":"publisher","first-page":"8967803","DOI":"10.1155\/2017\/8967803","volume":"2017","author":"V.H Eisenberg","year":"2017","unstructured":"Eisenberg, V. H. et al. Sonographic signs of adenomyosis are prevalent in women undergoing surgery for endometriosis and may suggest a higher risk of infertility. Biomed Res. Int. 2017, 8967803 (2017).","journal-title":"Biomed Res. Int."},{"key":"32974_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/uog.26159","volume":"62","author":"I Mishra","year":"2023","unstructured":"Mishra, I. et al. Prevalence of adenomyosis in women with subfertility: Systematic review and meta-analysis. Ultrasound Obstet. Gynecol. 62, 23\u201341 (2023).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"32974_CR8","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12958-016-0185-6","volume":"14","author":"JM Puente","year":"2016","unstructured":"Puente, J. M. et al. Adenomyosis in infertile women: Prevalence and the role of 3D ultrasound as a marker of severity of the disease. Reprod. Biol. Endocrinol. 14, 60 (2016).","journal-title":"Reprod. Biol. Endocrinol."},{"key":"32974_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12958-023-01182-7","volume":"22","author":"E Ju\u00e1rez-Barber","year":"2024","unstructured":"Ju\u00e1rez-Barber, E. et al. Transcriptome analysis of adenomyosis eutopic endometrium reveals molecular mechanisms involved in adenomyosis-related implantation failure and pregnancy disorders. Reprod. Biol. Endocrinol. 22, 10 (2024).","journal-title":"Reprod. Biol. Endocrinol."},{"key":"32974_CR10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/OGX.0000000000000346","volume":"71","author":"T Harada","year":"2016","unstructured":"Harada, T. et al. The impact of adenomyosis on women\u2019s fertility. Obstet. Gynecol. Surv. 71, 557\u2013568 (2016).","journal-title":"Obstet. Gynecol. Surv."},{"key":"32974_CR11","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3109\/09513590.2010.491925","volume":"27","author":"J Hatok","year":"2011","unstructured":"Hatok, J. et al. Endometrial aromatase mRNA as a possible screening tool for advanced endometriosis and adenomyosis. Gynecol. Endocrinol. 27, 331\u2013336 (2011).","journal-title":"Gynecol. Endocrinol."},{"key":"32974_CR12","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.bpobgyn.2006.01.010","volume":"20","author":"J Kitawaki","year":"2006","unstructured":"Kitawaki, J. Adenomyosis: the pathophysiology of an oestrogen-dependent disease. Best Pract. Res. Clin. Obstet. Gynaecol. 20, 493\u2013502 (2006).","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"32974_CR13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.ejogrb.2013.05.007","volume":"170","author":"Y Xiao","year":"2013","unstructured":"Xiao, Y. et al. Expression of integrin \u03b23 and osteopontin in the eutopic endometrium of adenomyosis during the implantation window. Eur. J. Obstet. Gynecol. Reprod. Biol. 170, 419\u2013422 (2013).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"32974_CR14","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.3390\/jcm10112355","volume":"10","author":"D. Decter","year":"2021","unstructured":"Decter, D., Arbib, N., Markovitz, H., Seidman, D. S. & Eisenberg, V. H. Sonographic signs of adenomyosis in women with endometriosis are associated with infertility. J. Clin. Med. 10, 2355 (2021).","journal-title":"J. Clin. Med."},{"key":"32974_CR15","doi-asserted-by":"crossref","unstructured":"Vannuccini, S. & Petraglia, F. Recent advances in understanding and managing adenomyosis. [version 1; peer review: 2 approved]. F1000Res. 8, (2019).","DOI":"10.12688\/f1000research.17242.1"},{"key":"32974_CR16","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1007\/s43032-021-00679-z","volume":"28","author":"L Buggio","year":"2021","unstructured":"Buggio, L., Dridi, D. & Barbara, G. Adenomyosis: Impact on fertility and obstetric outcomes. Reprod. Sci. 28, 3081\u20133084 (2021).","journal-title":"Reprod. Sci."},{"key":"32974_CR17","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.fertnstert.2017.06.025","volume":"108","author":"G Younes","year":"2017","unstructured":"Younes, G. & Tulandi, T. Effects of adenomyosis on in vitro fertilization treatment outcomes: A meta-analysis. Fertil. Steril. 108, 483\u2013490e3 (2017).","journal-title":"Fertil. Steril."},{"key":"32974_CR18","doi-asserted-by":"publisher","first-page":"e0220256","DOI":"10.1371\/journal.pone.0220256","volume":"14","author":"T Harada","year":"2019","unstructured":"Harada, T. et al. Adverse obstetrical outcomes for women with endometriosis and adenomyosis: A large cohort of the Japan environment and children\u2019s study. PLoS ONE. 14, e0220256 (2019).","journal-title":"PLoS ONE"},{"key":"32974_CR19","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1007\/s43032-021-00818-6","volume":"29","author":"M Cozzolino","year":"2022","unstructured":"Cozzolino, M. et al. The effect of uterine adenomyosis on IVF outcomes: A systematic review and Meta-analysis. Reprod. Sci. 29, 3177\u20133193 (2022).","journal-title":"Reprod. Sci."},{"key":"32974_CR20","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ejogrb.2011.04.030","volume":"158","author":"MF Costello","year":"2011","unstructured":"Costello, M. F., Lindsay, K. & McNally, G. The effect of adenomyosis on in vitro fertilisation and intra-cytoplasmic sperm injection treatment outcome. Eur. J. Obstet. Gynecol. Reprod. Biol. 158, 229\u2013234 (2011).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"32974_CR21","doi-asserted-by":"publisher","first-page":"hoab015","DOI":"10.1093\/hropen\/hoab015","volume":"2021","author":"C. Higgins","year":"2021","unstructured":"Higgins, C. et al. The impact of adenomyosis on IVF outcomes: A prospective cohort study. Hum. Reprod. Open 2021, hoab015 (2021).","journal-title":"Hum. Reprod. Open"},{"key":"32974_CR22","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.fertnstert.2022.12.021","volume":"119","author":"ES Dason","year":"2023","unstructured":"Dason, E. S. et al. Pregnancy outcomes with donor oocyte embryos in patients diagnosed with adenomyosis using the morphological uterus sonographic assessment criteria. Fertil. Steril. 119, 484\u2013489 (2023).","journal-title":"Fertil. Steril."},{"key":"32974_CR23","doi-asserted-by":"publisher","first-page":"609771","DOI":"10.3389\/fendo.2021.609771","volume":"12","author":"J Lan","year":"2021","unstructured":"Lan, J. et al. Ultra-Long GnRH agonist protocol during IVF\/ICSI improves pregnancy outcomes in women with adenomyosis: A retrospective cohort study. Front. Endocrinol. (Lausanne). 12, 609771 (2021).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"32974_CR24","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.3109\/09513590.2013.824960","volume":"29","author":"Z Niu","year":"2013","unstructured":"Niu, Z., Chen, Q., Sun, Y. & Feng, Y. Long-term pituitary downregulation before frozen embryo transfer could improve pregnancy outcomes in women with adenomyosis. Gynecol. Endocrinol. 29, 1026\u20131030 (2013).","journal-title":"Gynecol. Endocrinol."},{"key":"32974_CR25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.5653\/cerm.2016.43.3.169","volume":"43","author":"CW Park","year":"2016","unstructured":"Park, C. W., Choi, M. H., Yang, K. M. & Song, I. O. Pregnancy rate in women with adenomyosis undergoing fresh or frozen embryo transfer cycles following gonadotropin-releasing hormone agonist treatment. Clin. Exp. Reprod. Med. 43, 169\u2013173 (2016).","journal-title":"Clin. Exp. Reprod. Med."},{"key":"32974_CR26","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/j.1600-0412.2012.01350.x","volume":"91","author":"AM Badawy","year":"2012","unstructured":"Badawy, A. M., Elnashar, A. M. & Mosbah, A. A. Aromatase inhibitors or gonadotropin-releasing hormone agonists for the management of uterine adenomyosis: A randomized controlled trial. Acta Obstet. Gynecol. Scand. 91, 489\u2013495 (2012).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"32974_CR27","doi-asserted-by":"publisher","first-page":"1468e9","DOI":"10.1016\/j.fertnstert.2006.09.010","volume":"87","author":"F Kimura","year":"2007","unstructured":"Kimura, F. et al. Concomitant treatment of severe uterine adenomyosis in a premenopausal woman with an aromatase inhibitor and a gonadotropin-releasing hormone agonist. Fertil. Steril. 87, 1468e9\u2013146812 (2007).","journal-title":"Fertil. Steril."},{"key":"32974_CR28","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.rbmo.2023.03.010","volume":"47","author":"S Sharma","year":"2023","unstructured":"Sharma, S. et al. Low-dose letrozole - an effective option for women with symptomatic adenomyosis awaiting IVF: A pilot randomized controlled trial. Reprod. Biomed. Online. 47, 84\u201393 (2023).","journal-title":"Reprod. Biomed. Online"},{"key":"32974_CR29","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/uog.14806","volume":"46","author":"T den \u2003\u2002Van","year":"2015","unstructured":"den Van, T. et al. Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the morphological uterus sonographic assessment (MUSA) group. Ultrasound Obstet. Gynecol. 46, 284\u2013298 (2015).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"32974_CR30","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/uog.19096","volume":"53","author":"T den \u2003\u2002Van","year":"2019","unstructured":"den Van, T. et al. Sonographic classification and reporting system for diagnosing adenomyosis. Ultrasound Obstet. Gynecol. 53, 576\u2013582 (2019).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"32974_CR31","doi-asserted-by":"publisher","first-page":"hoy011","DOI":"10.1093\/hropen\/hoy011","volume":"2018","author":"V. Stanekova","year":"2018","unstructured":"Stanekova, V., Woodman, R. J. & Tremellen, K. The rate of euploid miscarriage is increased in the setting of adenomyosis. Hum. Reprod. Open 2018, hoy011 (2018).","journal-title":"Hum. Reprod. Open"},{"key":"32974_CR32","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/s12905-024-03245-2","volume":"24","author":"J Li","year":"2024","unstructured":"Li, J. et al. Prevalence and risk factors for chronic endometritis in patients with adenomyosis and infertility: a retrospective cohort study. BMC Womens Health. 24, 403 (2024).","journal-title":"BMC Womens Health"},{"key":"32974_CR33","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.rbmo.2020.02.011","volume":"40","author":"H Abu Hashim","year":"2020","unstructured":"Abu Hashim, H., Elaraby, S., Fouda, A. A. & Rakhawy, M. E. The prevalence of adenomyosis in an infertile population: a cross-sectional study. Reprod. Biomed. Online. 40, 842\u2013850 (2020).","journal-title":"Reprod. Biomed. Online"},{"key":"32974_CR34","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/S0015-0282(00)00708-1","volume":"74","author":"JL Frattarelli","year":"2000","unstructured":"Frattarelli, J. L., Lauria-Costab, D. F., Miller, B. T., Bergh, P. A. & Scott, R. T. Basal antral follicle number and mean ovarian diameter predict cycle cancellation and ovarian responsiveness in assisted reproductive technology cycles. Fertil. Steril. 74, 512\u2013517 (2000).","journal-title":"Fertil. Steril."},{"key":"32974_CR35","doi-asserted-by":"publisher","first-page":"19326","DOI":"10.1038\/s41598-021-98918-5","volume":"11","author":"M Li","year":"2021","unstructured":"Li, M., Xu, L., Zhao, H., Du, Y. & Yan, L. Effects of artificial cycles with and without gonadotropin-releasing hormone agonist pretreatment on frozen embryo transfer outcomes in patients with adenomyosis. Sci. Rep. 11, 19326 (2021).","journal-title":"Sci. Rep."},{"key":"32974_CR36","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.rbmo.2019.09.005","volume":"40","author":"G Gao","year":"2020","unstructured":"Gao, G. et al. Endometrial thickness and IVF cycle outcomes: a meta-analysis. Reprod. Biomed. Online. 40, 124\u2013133 (2020).","journal-title":"Reprod. Biomed. Online"},{"key":"32974_CR37","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.fertnstert.2023.11.034","volume":"121","author":"M Cozzolino","year":"2024","unstructured":"Cozzolino, M. et al. Impact of adenomyosis on in vitro fertilization outcomes in women undergoing donor oocyte transfers: a prospective observational study. Fertil. Steril. 121, 480\u2013488 (2024).","journal-title":"Fertil. Steril."},{"key":"32974_CR38","doi-asserted-by":"publisher","first-page":"1246819","DOI":"10.3389\/fendo.2023.1246819","volume":"14","author":"S Wang","year":"2023","unstructured":"Wang, S. & Duan, H. The role of the junctional zone in the management of adenomyosis with infertility. Front. Endocrinol. (Lausanne). 14, 1246819 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"32974_CR39","doi-asserted-by":"publisher","first-page":"6741","DOI":"10.1038\/s41598-023-34045-7","volume":"13","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Impact of adenomyosis and endometriosis on IVF\/ICSI pregnancy outcome in patients undergoing gonadotropin-releasing hormone agonist treatment and frozen embryo transfer. Sci. Rep. 13, 6741 (2023).","journal-title":"Sci. Rep."},{"key":"32974_CR40","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1111\/aogs.14812","volume":"103","author":"S Alson","year":"2024","unstructured":"Alson, S., Jokubkiene, L., Henic, E. & Sladkevicius, P. Prevalence of adenomyosis features in women scheduled for assisted reproductive treatment, using the morphological uterus sonographic assessment group definitions. Acta Obstet. Gynecol. Scand. 103, 1142\u20131152 (2024).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"32974_CR41","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.rbmo.2017.06.026","volume":"35","author":"D Mavrelos","year":"2017","unstructured":"Mavrelos, D. et al. The impact of adenomyosis on the outcome of IVF-embryo transfer. Reprod. Biomed. Online. 35, 549\u2013554 (2017).","journal-title":"Reprod. Biomed. Online"},{"key":"32974_CR42","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3109\/01443615.2011.624208","volume":"32","author":"SK Sunkara","year":"2012","unstructured":"Sunkara, S. K. & Khan, K. S. Adenomyosis and female fertility: A critical review of the evidence. J. Obstet. Gynaecol. 32, 113\u2013116 (2012).","journal-title":"J. Obstet. Gynaecol."},{"key":"32974_CR43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.rbmo.2018.09.014","volume":"38","author":"S Sharma","year":"2019","unstructured":"Sharma, S. et al. Does presence of adenomyosis affect reproductive outcome in IVF cycles? A retrospective analysis of 973 patients. Reprod. Biomed. Online. 38, 13\u201321 (2019).","journal-title":"Reprod. Biomed. Online"},{"key":"32974_CR44","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1016\/j.fertnstert.2011.02.051","volume":"95","author":"MK Mehasseb","year":"2011","unstructured":"Mehasseb, M. K. et al. Estrogen and progesterone receptor isoform distribution through the menstrual cycle in Uteri with and without adenomyosis. Fertil. Steril. 95, 2228\u20132235 (2011).","journal-title":"Fertil. Steril."},{"key":"32974_CR45","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1093\/humupd\/dmu053","volume":"21","author":"DK Hapangama","year":"2015","unstructured":"Hapangama, D. K., Kamal, A. M. & Bulmer, J. N. Estrogen receptor \u03b2: The guardian of the endometrium. Hum. Reprod. Update 21, 174\u2013193 (2015).","journal-title":"Hum. Reprod. Update"},{"key":"32974_CR46","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.3390\/jcm11154407","volume":"11","author":"M. Sztachelska","year":"2022","unstructured":"Sztachelska, M. et al. Functional implications of estrogen and progesterone receptors expression in adenomyosis, potential targets for endocrinological therapy. J. Clin. Med. 11, 4407 (2022).","journal-title":"J. Clin. Med."},{"key":"32974_CR47","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2147\/IJWH.S29154","volume":"4","author":"H Maia","year":"2012","unstructured":"Maia, H., Haddad, C. & Casoy, J. Correlation between aromatase expression in the eutopic endometrium of symptomatic patients and the presence of endometriosis. Int. J. Womens Health. 4, 61\u201365 (2012).","journal-title":"Int. J. Womens Health"},{"key":"32974_CR48","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/09513590.2016.1232902","volume":"32","author":"MR Orazov","year":"2016","unstructured":"Orazov, M. R. et al. Proangiogenic features in chronic pelvic pain caused by adenomyosis. Gynecol. Endocrinol. 32, 7\u201310 (2016).","journal-title":"Gynecol. Endocrinol."},{"key":"32974_CR49","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/humrep\/der452","volume":"27","author":"PB Miller","year":"2012","unstructured":"Miller, P. B. et al. Endometrial receptivity defects during IVF cycles with and without letrozole. Hum. Reprod. 27, 881\u2013888 (2012).","journal-title":"Hum. Reprod."},{"key":"32974_CR50","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.3390\/jcm11144057","volume":"11","author":"K. N. Khan","year":"2022","unstructured":"Khan, K. N., Fujishita, A. & Mori, T. Pathogenesis of human adenomyosis: current Understanding and its association with infertility. J. Clin. Med. 11, 4057 (2022).","journal-title":"J. Clin. Med."},{"key":"32974_CR51","doi-asserted-by":"publisher","first-page":"1507252","DOI":"10.3389\/fendo.2025.1507252","volume":"16","author":"Y Han","year":"2025","unstructured":"Han, Y., Liu, C., Liu, D., Wu, L. & Huang, W. Pregnancy outcomes in freeze-all versus fresh embryo transfer cycles of women with adenomyosis and endometriosis: a systemic review and meta-analysis. Front. Endocrinol. (Lausanne). 16, 1507252 (2025).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"32974_CR52","doi-asserted-by":"publisher","first-page":"127","DOI":"10.5301\/je.5000261","volume":"8","author":"C Tosti","year":"2016","unstructured":"Tosti, C. et al. Current and future medical treatment of adenomyosis. J. Endometr. Pelvic Pain Disord. 8, 127\u2013135 (2016).","journal-title":"J. Endometr. Pelvic Pain Disord."},{"key":"32974_CR53","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.rbmo.2021.10.025","volume":"44","author":"EA Elgindy","year":"2022","unstructured":"Elgindy, E. A., Abdelghany, A. A., Sibai AbdAlsalam, H. & Mostafa, M. I. The novel incorporation of aromatase inhibitor in hormonal replacement therapy cycles: a randomized controlled trial. Reprod. Biomed. Online. 44, 641\u2013649 (2022).","journal-title":"Reprod. Biomed. Online"},{"key":"32974_CR54","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4103\/jhrs.jhrs_127_25","volume":"18","author":"M Karan","year":"2025","unstructured":"Karan, M., Paladhi, P., Kundu, D. & Sharma, S. Intramyometrial pregnancy with uterine rupture at Second-trimester after frozen embryo transfer. J. Hum. Reprod. Sci. 18, 177\u2013180 (2025).","journal-title":"J. Hum. Reprod. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32974-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32974-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32974-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T15:04:56Z","timestamp":1769180696000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32974-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["32974"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-32974-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,31]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Institute\u2019s Human Ethics Committee (IRM\/IEC\/BNC-IHP-03\/2022). Written informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"3112"}}